Global Pd-1 and Pd-L1 Inhibitors Market Growth 2021-2026

  • receipt Report ID : 255515
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 132
  • list Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Pd-1 and Pd-L1 Inhibitors will have significant change from previous year. By the most conservative estimates of global Pd-1 and Pd-L1 Inhibitors market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Pd-1 and Pd-L1 Inhibitors market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Pd-1 and Pd-L1 Inhibitors market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

PD-1

PD-L1

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Hospital Pharmacies

Retail Pharmacies

Specialty Pharmacies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Bristol-Myers Squibb

Merck

F. Hoffmann-La Roche

Sanofi

Amgen

Gilead Sciences

AstraZeneca

Novartis

Pfizer

Celgene

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pd-1 and Pd-L1 Inhibitors Consumption 2016-2026

2.1.2 Pd-1 and Pd-L1 Inhibitors Consumption CAGR by Region

2.2 Pd-1 and Pd-L1 Inhibitors Segment by Type

2.2.1 PD-1

2.2.2 PD-L1

2.3 Pd-1 and Pd-L1 Inhibitors Sales by Type

2.3.1 Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type (2016-2021)

2.3.2 Global Pd-1 and Pd-L1 Inhibitors Revenue and Market Share by Type (2016-2021)

2.3.3 Global Pd-1 and Pd-L1 Inhibitors Sale Price by Type (2016-2021)

2.4 Pd-1 and Pd-L1 Inhibitors Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Specialty Pharmacies

2.5 Pd-1 and Pd-L1 Inhibitors Sales by Application

2.5.1 Global Pd-1 and Pd-L1 Inhibitors Sale Market Share by Application (2016-2021)

2.5.2 Global Pd-1 and Pd-L1 Inhibitors Revenue and Market Share by Application (2016-2021)

2.5.3 Global Pd-1 and Pd-L1 Inhibitors Sale Price by Application (2016-2021)

3 Global Pd-1 and Pd-L1 Inhibitors by Company

3.1 Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Company

3.1.1 Global Pd-1 and Pd-L1 Inhibitors Sales by Company (2019-2021)

3.1.2 Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Company (2019-2021)

3.2 Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Company

3.2.1 Global Pd-1 and Pd-L1 Inhibitors Revenue by Company (2019-2021)

3.2.2 Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Company (2019-2021)

3.3 Global Pd-1 and Pd-L1 Inhibitors Sale Price by Company

3.4 Global Manufacturers Pd-1 and Pd-L1 Inhibitors Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pd-1 and Pd-L1 Inhibitors Product Location Distribution

3.4.2 Players Pd-1 and Pd-L1 Inhibitors Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Pd-1 and Pd-L1 Inhibitors by Region

4.1 Global Pd-1 and Pd-L1 Inhibitors by Region

4.1.1 Global Pd-1 and Pd-L1 Inhibitors Sales by Region

4.1.2 Global Pd-1 and Pd-L1 Inhibitors Revenue by Region

4.2 Americas Pd-1 and Pd-L1 Inhibitors Sales Growth

4.3 APAC Pd-1 and Pd-L1 Inhibitors Sales Growth

4.4 Europe Pd-1 and Pd-L1 Inhibitors Sales Growth

4.5 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Growth

5 Americas

5.1 Americas Pd-1 and Pd-L1 Inhibitors Sales by Country

5.1.1 Americas Pd-1 and Pd-L1 Inhibitors Sales by Country (2016-2021)

5.1.2 Americas Pd-1 and Pd-L1 Inhibitors Revenue by Country (2016-2021)

5.2 Americas Pd-1 and Pd-L1 Inhibitors Sales by Type

5.3 Americas Pd-1 and Pd-L1 Inhibitors Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pd-1 and Pd-L1 Inhibitors Sales by Region

6.1.1 APAC Pd-1 and Pd-L1 Inhibitors Sales by Region (2016-2021)

6.1.2 APAC Pd-1 and Pd-L1 Inhibitors Revenue by Region (2016-2021)

6.2 APAC Pd-1 and Pd-L1 Inhibitors Sales by Type

6.3 APAC Pd-1 and Pd-L1 Inhibitors Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Pd-1 and Pd-L1 Inhibitors by Country

7.1.1 Europe Pd-1 and Pd-L1 Inhibitors Sales by Country (2016-2021)

7.1.2 Europe Pd-1 and Pd-L1 Inhibitors Revenue by Country (2016-2021)

7.2 Europe Pd-1 and Pd-L1 Inhibitors Sales by Type

7.3 Europe Pd-1 and Pd-L1 Inhibitors Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pd-1 and Pd-L1 Inhibitors by Country

8.1.1 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales by Country (2016-2021)

8.1.2 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue by Country (2016-2021)

8.2 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales by Type

8.3 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Pd-1 and Pd-L1 Inhibitors Distributors

10.3 Pd-1 and Pd-L1 Inhibitors Customer

11 Global Pd-1 and Pd-L1 Inhibitors Market Forecast

11.1 Global Pd-1 and Pd-L1 Inhibitors Forecast by Region

11.1.1 Global Pd-1 and Pd-L1 Inhibitors Forecast by Regions (2021-2026)

11.2.2 Global Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Pd-1 and Pd-L1 Inhibitors Forecast by Type

11.7 Global Pd-1 and Pd-L1 Inhibitors Forecast by Application

12 Key Players Analysis

12.1 Bristol-Myers Squibb

12.1.1 Bristol-Myers Squibb Company Information

12.1.2 Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Product Offered

12.1.3 Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Bristol-Myers Squibb Main Business Overview

12.1.5 Bristol-Myers Squibb Latest Developments

12.2 Merck

12.2.1 Merck Company Information

12.2.2 Merck Pd-1 and Pd-L1 Inhibitors Product Offered

12.2.3 Merck Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Merck Main Business Overview

12.2.5 Merck Latest Developments

12.3 F. Hoffmann-La Roche

12.3.1 F. Hoffmann-La Roche Company Information

12.3.2 F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Product Offered

12.3.3 F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 F. Hoffmann-La Roche Main Business Overview

12.3.5 F. Hoffmann-La Roche Latest Developments

12.4 Sanofi

12.4.1 Sanofi Company Information

12.4.2 Sanofi Pd-1 and Pd-L1 Inhibitors Product Offered

12.4.3 Sanofi Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Sanofi Main Business Overview

12.4.5 Sanofi Latest Developments

12.5 Amgen

12.5.1 Amgen Company Information

12.5.2 Amgen Pd-1 and Pd-L1 Inhibitors Product Offered

12.5.3 Amgen Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Amgen Main Business Overview

12.5.5 Amgen Latest Developments

12.6 Gilead Sciences

12.6.1 Gilead Sciences Company Information

12.6.2 Gilead Sciences Pd-1 and Pd-L1 Inhibitors Product Offered

12.6.3 Gilead Sciences Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Gilead Sciences Main Business Overview

12.6.5 Gilead Sciences Latest Developments

12.7 AstraZeneca

12.7.1 AstraZeneca Company Information

12.7.2 AstraZeneca Pd-1 and Pd-L1 Inhibitors Product Offered

12.7.3 AstraZeneca Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 AstraZeneca Main Business Overview

12.7.5 AstraZeneca Latest Developments

12.8 Novartis

12.8.1 Novartis Company Information

12.8.2 Novartis Pd-1 and Pd-L1 Inhibitors Product Offered

12.8.3 Novartis Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Novartis Main Business Overview

12.8.5 Novartis Latest Developments

12.9 Pfizer

12.9.1 Pfizer Company Information

12.9.2 Pfizer Pd-1 and Pd-L1 Inhibitors Product Offered

12.9.3 Pfizer Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Pfizer Main Business Overview

12.9.5 Pfizer Latest Developments

12.10 Celgene

12.10.1 Celgene Company Information

12.10.2 Celgene Pd-1 and Pd-L1 Inhibitors Product Offered

12.10.3 Celgene Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Celgene Main Business Overview

12.10.5 Celgene Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Pd-1 and Pd-L1 Inhibitors Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of PD-1

Table 3. Major Players of PD-L1

Table 4. Global Pd-1 and Pd-L1 Inhibitors Sales by Type (2016-2021) & (K Units)

Table 5. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type (2016-2021)

Table 6. Global Pd-1 and Pd-L1 Inhibitors Revenue by Type (2016-2021) & ($ million)

Table 7. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Type (2016-2021)

Table 8. Global Pd-1 and Pd-L1 Inhibitors Sale Price by Type (2016-2021)

Table 9. Global Pd-1 and Pd-L1 Inhibitors Sales by Application (2016-2021) & (K Units)

Table 10. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application (2016-2021)

Table 11. Global Pd-1 and Pd-L1 Inhibitors Value by Application (2016-2021)

Table 12. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Application (2016-2021)

Table 13. Global Pd-1 and Pd-L1 Inhibitors Sale Price by Application (2016-2021)

Table 14. Global Pd-1 and Pd-L1 Inhibitors Sales by Company (2019-2021) & (K Units)

Table 15. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Company (2019-2021)

Table 16. Global Pd-1 and Pd-L1 Inhibitors Revenue by Company (2019-2021) ($ Millions)

Table 17. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Company (2019-2021)

Table 18. Global Pd-1 and Pd-L1 Inhibitors Sale Price by Company (2019-2021)

Table 19. Key Manufacturers Pd-1 and Pd-L1 Inhibitors Producing Area Distribution and Sales Area

Table 20. Players Pd-1 and Pd-L1 Inhibitors Products Offered

Table 21. Pd-1 and Pd-L1 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Pd-1 and Pd-L1 Inhibitors Sales by Region (2016-2021) (K Units)

Table 25. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Region (2016-2021)

Table 26. Global Pd-1 and Pd-L1 Inhibitors Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Region (2016-2021)

Table 28. Americas Pd-1 and Pd-L1 Inhibitors Sales by Country (2016-2021) & (K Units)

Table 29. Americas Pd-1 and Pd-L1 Inhibitors Sales Market Share by Country (2016-2021)

Table 30. Americas Pd-1 and Pd-L1 Inhibitors Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Country (2016-2021)

Table 32. Americas Pd-1 and Pd-L1 Inhibitors Sales by Type (2016-2021) & (K Units)

Table 33. Americas Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type (2016-2021)

Table 34. Americas Pd-1 and Pd-L1 Inhibitors Sales by Application (2016-2021) & (K Units)

Table 35. Americas Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application (2016-2021)

Table 36. APAC Pd-1 and Pd-L1 Inhibitors Sales by Region (2016-2021) & (K Units)

Table 37. APAC Pd-1 and Pd-L1 Inhibitors Sales Market Share by Region (2016-2021)

Table 38. APAC Pd-1 and Pd-L1 Inhibitors Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Region (2016-2021)

Table 40. APAC Pd-1 and Pd-L1 Inhibitors Sales by Type (2016-2021) & (K Units)

Table 41. APAC Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type (2016-2021)

Table 42. APAC Pd-1 and Pd-L1 Inhibitors Sales by Application (2016-2021) & (K Units)

Table 43. APAC Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application (2016-2021)

Table 44. Europe Pd-1 and Pd-L1 Inhibitors Sales by Country (2016-2021) & (K Units)

Table 45. Europe Pd-1 and Pd-L1 Inhibitors Sales Market Share by Country (2016-2021)

Table 46. Europe Pd-1 and Pd-L1 Inhibitors Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Country (2016-2021)

Table 48. Europe Pd-1 and Pd-L1 Inhibitors Sales by Type (2016-2021) & (K Units)

Table 49. Europe Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type (2016-2021)

Table 50. Europe Pd-1 and Pd-L1 Inhibitors Sales by Application (2016-2021) & (K Units)

Table 51. Europe Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales by Country (2016-2021) & (K Units)

Table 53. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales by Type (2016-2021) & (K Units)

Table 57. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales by Application (2016-2021) & (K Units)

Table 59. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application (2016-2021)

Table 60. Key and Potential Regions of Pd-1 and Pd-L1 Inhibitors

Table 61. Key Application and Potential Industries of Pd-1 and Pd-L1 Inhibitors

Table 62. Key Challenges of Pd-1 and Pd-L1 Inhibitors

Table 63. Key Trends of Pd-1 and Pd-L1 Inhibitors

Table 64. Pd-1 and Pd-L1 Inhibitors Distributors List

Table 65. Pd-1 and Pd-L1 Inhibitors Customer List

Table 66. Global Pd-1 and Pd-L1 Inhibitors Sales Forecast by Region (2021-2026) & (K Units)

Table 67. Global Pd-1 and Pd-L1 Inhibitors Consumption Market Forecast by Region

Table 68. Global Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Region (2021-2026) & ($ millions)

Table 69. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share Forecast by Region (2021-2026)

Table 70. Americas Pd-1 and Pd-L1 Inhibitors Sales Forecast by Country (2021-2026) & (K Units)

Table 71. Americas Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Country (2021-2026) & ($ millions)

Table 72. APAC Pd-1 and Pd-L1 Inhibitors Sales Forecast by Region (2021-2026) & (K Units)

Table 73. APAC Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Region (2021-2026) & ($ millions)

Table 74. Europe Pd-1 and Pd-L1 Inhibitors Sales Forecast by Country (2021-2026) & (K Units)

Table 75. Europe Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Country (2021-2026) & ($ millions)

Table 76. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Forecast by Country (2021-2026) & (K Units)

Table 77. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Global Pd-1 and Pd-L1 Inhibitors Sales Forecast by Type (2021-2026) & (K Units)

Table 79. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share Forecast by Type (2021-2026)

Table 80. Global Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 81. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share Forecast by Type (2021-2026)

Table 82. Global Pd-1 and Pd-L1 Inhibitors Sales Forecast by Application (2021-2026) & (K Units)

Table 83. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share Forecast by Application (2021-2026)

Table 84. Global Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 85. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share Forecast by Application (2021-2026)

Table 86. Bristol-Myers Squibb Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 87. Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Product Offered

Table 88. Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 89. Bristol-Myers Squibb Main Business

Table 90. Bristol-Myers Squibb Latest Developments

Table 91. Merck Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 92. Merck Pd-1 and Pd-L1 Inhibitors Product Offered

Table 93. Merck Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 94. Merck Main Business

Table 95. Merck Latest Developments

Table 96. F. Hoffmann-La Roche Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 97. F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Product Offered

Table 98. F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 99. F. Hoffmann-La Roche Main Business

Table 100. F. Hoffmann-La Roche Latest Developments

Table 101. Sanofi Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 102. Sanofi Pd-1 and Pd-L1 Inhibitors Product Offered

Table 103. Sanofi Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 104. Sanofi Main Business

Table 105. Sanofi Latest Developments

Table 106. Amgen Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 107. Amgen Pd-1 and Pd-L1 Inhibitors Product Offered

Table 108. Amgen Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 109. Amgen Main Business

Table 110. Amgen Latest Developments

Table 111. Gilead Sciences Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 112. Gilead Sciences Pd-1 and Pd-L1 Inhibitors Product Offered

Table 113. Gilead Sciences Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 114. Gilead Sciences Main Business

Table 115. Gilead Sciences Latest Developments

Table 116. AstraZeneca Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 117. AstraZeneca Pd-1 and Pd-L1 Inhibitors Product Offered

Table 118. AstraZeneca Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 119. AstraZeneca Main Business

Table 120. AstraZeneca Latest Developments

Table 121. Novartis Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 122. Novartis Pd-1 and Pd-L1 Inhibitors Product Offered

Table 123. Novartis Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 124. Novartis Main Business

Table 125. Novartis Latest Developments

Table 126. Pfizer Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 127. Pfizer Pd-1 and Pd-L1 Inhibitors Product Offered

Table 128. Pfizer Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 129. Pfizer Main Business

Table 130. Pfizer Latest Developments

Table 131. Celgene Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 132. Celgene Pd-1 and Pd-L1 Inhibitors Product Offered

Table 133. Celgene Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 134. Celgene Main Business

Table 135. Celgene Latest Developments

List of Figures

Figure 1. Picture of Pd-1 and Pd-L1 Inhibitors

Figure 2. Pd-1 and Pd-L1 Inhibitors Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pd-1 and Pd-L1 Inhibitors Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Pd-1 and Pd-L1 Inhibitors Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Pd-1 and Pd-L1 Inhibitors Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of PD-1

Figure 10. Product Picture of PD-L1

Figure 11. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type in 2020

Figure 12. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Type (2016-2021)

Figure 13. Pd-1 and Pd-L1 Inhibitors Consumed in Hospital Pharmacies

Figure 14. Global Pd-1 and Pd-L1 Inhibitors Market: Hospital Pharmacies (2016-2021) & (K Units)

Figure 15. Pd-1 and Pd-L1 Inhibitors Consumed in Retail Pharmacies

Figure 16. Global Pd-1 and Pd-L1 Inhibitors Market: Retail Pharmacies (2016-2021) & (K Units)

Figure 17. Pd-1 and Pd-L1 Inhibitors Consumed in Specialty Pharmacies

Figure 18. Global Pd-1 and Pd-L1 Inhibitors Market: Specialty Pharmacies (2016-2021) & (K Units)

Figure 19. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application (2016-2021)

Figure 20. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Application in 2020

Figure 21. Pd-1 and Pd-L1 Inhibitors Revenue Market by Company in 2020 ($ Million)

Figure 22. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Company in 2020

Figure 23. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Regions (2016-2021)

Figure 24. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Region in 2020

Figure 25. Americas Pd-1 and Pd-L1 Inhibitors Sales 2016-2021 (K Units)

Figure 26. Americas Pd-1 and Pd-L1 Inhibitors Revenue 2016-2021 ($ Millions)

Figure 27. APAC Pd-1 and Pd-L1 Inhibitors Sales 2016-2021 (K Units)

Figure 28. APAC Pd-1 and Pd-L1 Inhibitors Revenue 2016-2021 ($ Millions)

Figure 29. Europe Pd-1 and Pd-L1 Inhibitors Sales 2016-2021 (K Units)

Figure 30. Europe Pd-1 and Pd-L1 Inhibitors Revenue 2016-2021 ($ Millions)

Figure 31. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales 2016-2021 (K Units)

Figure 32. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue 2016-2021 ($ Millions)

Figure 33. Americas Pd-1 and Pd-L1 Inhibitors Sales Market Share by Country in 2020

Figure 34. Americas Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Country in 2020

Figure 35. Americas Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type in 2020

Figure 36. Americas Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application in 2020

Figure 37. United States Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 38. Canada Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 39. Mexico Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 40. Brazil Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 41. APAC Pd-1 and Pd-L1 Inhibitors Sales Market Share by Region in 2020

Figure 42. APAC Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Regions in 2020

Figure 43. APAC Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type in 2020

Figure 44. APAC Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application in 2020

Figure 45. China Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 46. Japan Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 47. Korea Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 48. Southeast Asia Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 49. India Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 50. Australia Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 51. Europe Pd-1 and Pd-L1 Inhibitors Sales Market Share by Country in 2020

Figure 52. Europe Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Country in 2020

Figure 53. Europe Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type in 2020

Figure 54. Europe Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application in 2020

Figure 55. Germany Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 56. France Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 57. UK Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 58. Italy Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 59. Russia Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 60. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Market Share by Country in 2020

Figure 61. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Country in 2020

Figure 62. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type in 2020

Figure 63. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application in 2020

Figure 64. Egypt Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 65. South Africa Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 66. Israel Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 67. Turkey Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 68. GCC Country Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

Please fill the form below, to recieve the report sample


+1